TY - JOUR
T1 - A reference map of potential determinants for the human serum metabolome
AU - Bar, Noam
AU - Korem, Tal
AU - Weissbrod, Omer
AU - Zeevi, David
AU - Rothschild, Daphna
AU - Leviatan, Sigal
AU - Kosower, Noa
AU - Lotan-Pompan, Maya
AU - Weinberger, Adina
AU - Le Roy, Caroline I.
AU - Menni, Cristina
AU - Visconti, Alessia
AU - Falchi, Mario
AU - Spector, Tim D.
AU - The IMI DIRECT consortium
AU - Vestergaard, Henrik
AU - Arumugam, Manimozhiyan
AU - Hansen, Torben
AU - Allin, Kristine
AU - Hansen, Tue
AU - Hong, Mun Gwan
AU - Schwenk, Jochen
AU - Haussler, Ragna
AU - Dale, Matilda
AU - Giorgino, Toni
AU - Rodriquez, Marianne
AU - Perry, Mandy
AU - Nice, Rachel
AU - McDonald, Timothy
AU - Hattersley, Andrew
AU - Jones, Angus
AU - Graefe-Mody, Ulrike
AU - Baum, Patrick
AU - Grempler, Rolf
AU - Thomas, Cecilia Engel
AU - Masi, Federico De
AU - Brorsson, Caroline Anna
AU - Mazzoni, Gianluca
AU - Allesøe, Rosa
AU - Loftus, Heather
AU - Cabrelli, Louise
AU - McCarthy, Mark
AU - Deshmukh, Harshal
AU - White, Margaret
AU - Donnelly, Louise
AU - Brown, Andrew
AU - Palmer, Colin
AU - Davtian, David
AU - Dawed, Adem
AU - Forgie, Ian
AU - Pearson, Ewan
AU - Adamski, Jerzy
AU - Franks, Paul W.
AU - Pedersen, Oluf
AU - Segal, Eran
N1 - Funding Information:
Acknowledgements We thank past and present members of the Segal group for discussions. N.B. received a PhD scholarship for Data Science by the Israeli Council for Higher Education (CHE) via the Weizmann Data Science Research Center and is supported by a research grant from Madame Olga Klein Astrachan. T.K. is a CIFAR Azrieli Global Scholar in the Humans & the Microbiome Program. E.S. is supported by the Crown Human Genome Center, by D. L. Schwarz, J. N. Halpern and L. Steinberg, and by grants funded by the European Research Council and the Israel Science Foundation. The work leading to this publication has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no.115317 (DIRECT), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and in-kind contribution from EFPIA companies. We thank A. Dutta for introducing us to the DIRECT consortium dataset.
Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature Limited.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/12/3
Y1 - 2020/12/3
N2 - The serum metabolome contains a plethora of biomarkers and causative agents of various diseases, some of which are endogenously produced and some that have been taken up from the environment1. The origins of specific compounds are known, including metabolites that are highly heritable2,3, or those that are influenced by the gut microbiome4, by lifestyle choices such as smoking5, or by diet6. However, the key determinants of most metabolites are still poorly understood. Here we measured the levels of 1,251 metabolites in serum samples from a unique and deeply phenotyped healthy human cohort of 491 individuals. We applied machine-learning algorithms to predict metabolite levels in held-out individuals on the basis of host genetics, gut microbiome, clinical parameters, diet, lifestyle and anthropometric measurements, and obtained statistically significant predictions for more than 76% of the profiled metabolites. Diet and microbiome had the strongest predictive power, and each explained hundreds of metabolites—in some cases, explaining more than 50% of the observed variance. We further validated microbiome-related predictions by showing a high replication rate in two geographically independent cohorts7,8 that were not available to us when we trained the algorithms. We used feature attribution analysis9 to reveal specific dietary and bacterial interactions. We further demonstrate that some of these interactions might be causal, as some metabolites that we predicted to be positively associated with bread were found to increase after a randomized clinical trial of bread intervention. Overall, our results reveal potential determinants of more than 800 metabolites, paving the way towards a mechanistic understanding of alterations in metabolites under different conditions and to designing interventions for manipulating the levels of circulating metabolites.
AB - The serum metabolome contains a plethora of biomarkers and causative agents of various diseases, some of which are endogenously produced and some that have been taken up from the environment1. The origins of specific compounds are known, including metabolites that are highly heritable2,3, or those that are influenced by the gut microbiome4, by lifestyle choices such as smoking5, or by diet6. However, the key determinants of most metabolites are still poorly understood. Here we measured the levels of 1,251 metabolites in serum samples from a unique and deeply phenotyped healthy human cohort of 491 individuals. We applied machine-learning algorithms to predict metabolite levels in held-out individuals on the basis of host genetics, gut microbiome, clinical parameters, diet, lifestyle and anthropometric measurements, and obtained statistically significant predictions for more than 76% of the profiled metabolites. Diet and microbiome had the strongest predictive power, and each explained hundreds of metabolites—in some cases, explaining more than 50% of the observed variance. We further validated microbiome-related predictions by showing a high replication rate in two geographically independent cohorts7,8 that were not available to us when we trained the algorithms. We used feature attribution analysis9 to reveal specific dietary and bacterial interactions. We further demonstrate that some of these interactions might be causal, as some metabolites that we predicted to be positively associated with bread were found to increase after a randomized clinical trial of bread intervention. Overall, our results reveal potential determinants of more than 800 metabolites, paving the way towards a mechanistic understanding of alterations in metabolites under different conditions and to designing interventions for manipulating the levels of circulating metabolites.
KW - Databases
KW - Machine learning
KW - Metabolomics
KW - Microbiology
UR - http://www.scopus.com/inward/record.url?scp=85095943937&partnerID=8YFLogxK
U2 - 10.1038/s41586-020-2896-2
DO - 10.1038/s41586-020-2896-2
M3 - Article
C2 - 33177712
AN - SCOPUS:85095943937
SN - 0028-0836
VL - 588
SP - 135
EP - 140
JO - Nature
JF - Nature
ER -